The contrasting roles of Th17 immunity in human health and disease

Microbiology and Immunology

Volumn 61, Issue 2, 2017, Pages 49-56

  Hoe, Edwin ^a   Anderson, Jeremy ^a   Nathanielsz, Jordan ^a   Toh, Zheng Quan ^a   Marimla, Rachel ^a   Balloch, Anne ^a   Licciardi, Paul V ^a,b  

^a MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

autoimmune; infection; inflammation; pneumococcal

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ANTIBODY; INTERLEUKIN DERIVATIVE;

AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL MATURATION; CELL POPULATION; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOREGULATION; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; NONHUMAN; PNEUMOCOCCAL INFECTION; PROTEIN FUNCTION; PROTEIN SYNTHESIS REGULATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS; STREPTOCOCCUS PNEUMONIAE; SYSTEMS BIOLOGY; TH17 CELL; COMMUNICABLE DISEASE; IMMUNOLOGY; PATHOLOGY;

AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; HUMANS; INTERLEUKINS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 85016304592     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12471     Document Type: Review

References (86)

1. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. (2005) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986. J Immunol 175:5–14.
2. Kaiko G.E., Horvat J.C., Beagley K.W., Hansbro P.M. (2008) Immunological decision-making: how does the immune system decide to mount a helper T-cell response? Immunology 123: 326–38.
3. Marwaha A.K., Leung N.J., McMurchy A.N., Levings M.K. (2012) TH17 cells in autoimmunity and immunodeficiency: Protective or pathogenic? Front Immunol 3: 129.
4. Waite J.C., Skokos D. (2012) Th17 response and inflammatory autoimmune diseases. Int J Inflam 2012: 819467.
5. Noack M., Miossec P. (2014) Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev 13: 668–77.
6. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235–38.
7. Buckner J.H. (2010) Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol 10: 849–59.
8. Carrier Y., Yuan J., Kuchroo V.K., Weiner H.L. (2007) Th3 cells in peripheral tolerance. II. TGF-beta-transgenic Th3 cells rescue IL-2-deficient mice from autoimmunity. J Immunol 178: 172–8.
9. Campbell D.J., Koch M.A. (2011) Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol 11: 119–30.
10. Horwitz D.A., Zheng S.G., Gray J.D. (2008) Natural and TGF-beta-induced Foxp3(+)CD4(+) CD25(+) regulatory T cells are not mirror images of each other. Trends Immunol 29: 429–35.
11. Korn T., Bettelli E., Oukka M., Kuchroo V.K. (2009) IL-17 and Th17 Cells. Annu Rev Immunol 27: 485–517.
12. Peck A., Mellins E.D. (2010) Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology 129: 147–53.
13. Zheng S.G. (2013) Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are they mutually exclusive? Am J Clin Exp Immunol 2: 94–106.
14. Battaglia M., Gregori S., Bacchetta R., Roncarolo M.G. (2006) Tr1 cells: From discovery to their clinical application. Semin Immunol 18: 120–7.
15. Astier A.L., Meiffren G., Freeman S., Hafler D.A. (2006) Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis. J Clin Invest 116: 3252–7.
16. Cottrez F., Hurst S.D., Coffman R.L., Groux H. (2000) T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 165: 4848–53.
17. Groux H., O'Garra A., Bigler M., Rouleau M., Antonenko S., de Vries J.E., Roncarolo M.G. (1997) A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737–42.
18. Crome S.Q., Clive B., Wang A.Y., Kang C.Y., Chow V., Yu J., Lai A., Ghahary A., Broady R., Levings M.K. (2010) Inflammatory effects of ex vivo human Th17 cells are suppressed by regulatory T cells. J Immunol 185: 3199–208.
19. Eisenstein E.M., Williams C.B. (2009) The T(reg)/Th17 cell balance: A new paradigm for autoimmunity. Pediatr Res 65: 26R–31R.
20. Yadav M., Stephan S., Bluestone J.A. (2013) Peripherally induced tregs—role in immune homeostasis and autoimmunity. Front Immunol 4: 232.
21. Nie H., Zheng Y., Li R., Guo T.B., He D., Fang L., Liu X., Xiao L., Chen X., Wan B., Chin Y.E., Zhang J.Z. (2013) Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-alpha in rheumatoid arthritis. Nat Med 19: 322–8.
22. Samson M., Audia S., Janikashvili N., Ciudad M., Trad M., Fraszczak J., Ornetti P., Maillefert J.F., Miossec P., Bonnotte B. (2012) Brief report: inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis. Arthritis Rheum 64: 2499–503.
23. Mondal S., Martinson J.A., Ghosh S., Watson R., Pahan K. (2012) Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline. PLoS ONE 7: e51869.
24. Louten J., Boniface K., de Waal Malefyt R. (2009) Development and function of TH17 cells in health and disease. J Allergy Clin Immunol 123: 1004–11.
25. Patel D.D., Kuchroo V.K. (2015) Th17 cell pathway in human immunity: Lessons from genetics and therapeutic interventions. Immunity 43: 1040–51.
26. Tzartos J.S., Friese M.A., Craner M.J., Palace J., Newcombe J., Esiri M.M., Fugger L. (2008) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 172: 146–55.
27. Miossec P., Korn T., Kuchroo V.K. (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888–98.
28. Montes M., Zhang X., Berthelot L., Laplaud D.A., Brouard S., Jin J., Rogan S., Armao D., Jewells V., Soulillou J.P., Markovic-Plese S. (2009) Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clin Immunol 130: 133–44.
29. Jadidi-Niaragh F., Mirshafiey A. (2011) Th17 cell, the new player of neuroinflammatory process in multiple sclerosis. Scand J Immunol 74: 1–13.
30. Schlegel P.M., Steiert I., Kotter I., Muller C.A. (2013) B cells contribute to heterogeneity of IL-17 producing cells in rheumatoid arthritis and healthy controls. PLoS ONE 8: e82580.
31. Lubberts E., Koenders M.I., van den Berg W.B. (2005) The role of T-cell interleukin-17 in conducting destructive arthritis: Lessons from animal models. Arthritis Res Ther 7: 29–37.
32. Colin E.M., Asmawidjaja P.S., van Hamburg J.P., Mus A.M., van Driel M., Hazes J.M., van Leeuwen J.P., Lubberts E. (2010) 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum 62: 132–42.
33. Shen H., Goodall J.C., Hill Gaston J.S. (2009) Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 60: 1647–56.
34. Eastaff-Leung N., Mabarrack N., Barbour A., Cummins A., Barry S. (2010) Foxp3+ regulatory T cells, Th17 effector cells, and cytokine environment in inflammatory bowel disease. J Clin Immunol 30: 80–9.
35. Gol-Ara M., Jadidi-Niaragh F., Sadria R., Azizi G., Mirshafiey A. (2012) The role of different subsets of regulatory T cells in immunopathogenesis of rheumatoid arthritis. Arthritis 2012: 805875.
36. Josefowicz S.Z., Lu L.F., Rudensky A.Y. (2012) Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30: 531–64.
37. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., Liew F.Y. (2007) IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 37: 3021–9.
38. McGovern J.L., Nguyen D.X., Notley C.A., Mauri C., Isenberg D.A., Ehrenstein M.R. (2012) Th17 cells are restrained by Treg cells via the inhibition of interleukin-6 in patients with rheumatoid arthritis responding to anti-tumor necrosis factor antibody therapy. Arthritis Rheum 64: 3129–38.
39. Boschetti G., Nancey S., Sardi F., Roblin X., Flourie B., Kaiserlian D. (2011) Therapy with anti-TNFalpha antibody enhances number and function of Foxp3(+) regulatory T cells in inflammatory bowel diseases. Inflamm Bowel Dis 17: 160–70.
40. Fletcher J.M., Lalor S.J., Sweeney C.M., Tubridy N., Mills K.H. (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162: 1–11.
41. Moffitt K.L., Gierahn T.M., Lu Y.J., Gouveia P., Alderson M., Flechtner J.B., Higgins D.E., Malley R. (2011) T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 9: 158–65.
42. Lundgren A., Bhuiyan T.R., Novak D., Kaim J., Reske A., Lu Y.J., Qadri F., Malley R. (2012) Characterization of Th17 responses to Streptococcus pneumoniae in humans: Comparisons between adults and children in a developed and a developing country. Vaccine 30: 3897–907.
43. Malley R., Trzcinski K., Srivastava A., Thompson C.M., Anderson P.W., Lipsitch M. (2005) CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 102: 4848–53.
44. Lu Y.J., Gross J., Bogaert D., Finn A., Bagrade L., Zhang Q., Kolls J.K., Srivastava A., Lundgren A., Forte S., Thompson C.M., Harney K.F., Anderson P.W., Lipsitch M., Malley R. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
45. Zhang Q., Leong S.C., McNamara P.S., Mubarak A., Malley R., Finn A. (2011) Characterisation of regulatory T cells in nasal associated lymphoid tissue in children: Relationships with pneumococcal colonization. PLoS Pathog 7: e1002175.
46. Marques J.M., Rial A., Munoz N., Pellay F.X., van Maele L., Leger H., Camou T., Sirard J.C., Benecke A., Chabalgoity J.A. (2012) Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-gamma-mediated immunity. Immunobiology 217: 420–9.
47. Zhang Z., Clarke T.B., Weiser J.N. (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899–909.
48. Mureithi M.W., Finn A., Ota M.O., Zhang Q., Davenport V., Mitchell T.J., Williams N.A., Adegbola R.A., Heyderman R.S. (2009) T cell memory response to pneumococcal protein antigens in an area of high pneumococcal carriage and disease. J Infect Dis 200: 783–93.
49. Richards L., Ferreira D.M., Miyaji E.N., Andrew P.W., Kadioglu A. (2010) The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. Immunobiology 215: 251–63.
50. Wilson R., Cohen J.M., Jose R.J., de Vogel C., Baxendale H., Brown J.S. (2015) Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses. Mucosal Immunol 8: 627–39.
51. Cohen J.M., Khandavilli S., Camberlein E., Hyams C., Baxendale H.E., Brown J.S. (2011) Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation. PLoS ONE 6: e25558.
52. Robinson K.M., Kolls J.K., Alcorn J.F. (2015) The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol 34: 59–67.
53. Shahangian A., Chow E.K., Tian X., Kang J.R., Ghaffari A., Liu S.Y., Belperio J.A., Cheng G., Deng J.C. (2009) Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice. J Clin Invest 119: 1910–20.
54. Schmid P., Selak S., Keller M., Luhan B., Magyarics Z., Seidel S., Schlick P., Reinisch C., Lingnau K., Nagy E., Grubeck-Loebenstein B. (2011) Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age. Vaccine 29: 3982–9.
55. Zhang Q., Arnaoutakis K., Murdoch C., Lakshman R., Race G., Burkinshaw R., Finn A. (2004) Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates. Pediatr Infect Dis J 23: 307–13.
56. Hoe E., Boelsen L.K., Toh Z.Q., Sun G.W., Koo G.C., Balloch A., Marimla R., Dunne E.M., Tikoduadua L., Russell F.M., Satzke C., Mulholland E.K., Licciardi P.V. (2015) Reduced IL-17A secretion is associated with high levels of pneumococcal nasopharyngeal carriage in Fijian children. PLoS ONE 10: e0129199.
57. Neill D.R., Fernandes V.E., Wisby L., Haynes A.R., Ferreira D.M., Laher A., Strickland N., Gordon S.B., Denny P., Kadioglu A., Andrew P.W. (2012) T regulatory cells control susceptibility to invasive pneumococcal pneumonia in mice. PLoS Pathog 8: e1002660.
58. Pido-Lopez J., Kwok W.W., Mitchell T.J., Heyderman R.S., Williams N.A. (2011) Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue. PLoS Pathog 7: e1002396.
59. Mubarak A., Ahmed M.S., Upile N., Vaughan C., Xie C., Sharma R., Acar P., McCormick M.S., Paton J.C., Mitchell T., Cunliffe N., Zhang Q. (2016) A dynamic relationship between mucosal T helper type 17 and regulatory T-cell populations in nasopharynx evolves with age and associates with the clearance of pneumococcal carriage in humans. Clin Microbiol Infect 22: 736e1–7.
60. Moffitt K.L., Malley R., Lu Y.J. (2012) Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS ONE 7: e43445.
61. Alderson M.R. (2016) Status of research and development of pediatric vaccines for Streptococcus pneumoniae. Vaccine 34: 2959–61.
62. Sutton C.E., Mielke L.A., Mills K.H. (2012) IL-17-producing gammadelta T cells and innate lymphoid cells. Eur J Immunol 42: 2221–31.
63. Conti H.R., Peterson A.C., Brane L., Huppler A.R., Hernandez-Santos N., Whibley N., Garg A.V., Simpson-Abelson M.R., Gibson G.A., Mamo A.J., Osborne L.C., Bishu S., Ghilardi N., Siebenlist U., Watkins S.C., Artis D., McGeachy M.J., Gaffen S.L. (2014) Oral-resident natural Th17 cells and gammadelta T cells control opportunistic Candida albicans infections. J Exp Med 211: 2075–84.
64. Maher C.O., Dunne K., Comerford R., O'Dea S., Loy A., Woo J., Rogers T.R., Mulcahy F., Dunne P.J., Doherty D.G. (2015) Candida albicans stimulates IL-23 release by human dendritic cells and downstream IL-17 secretion by Vdelta1 T cells. J Immunol 194: 5953–60.
65. Costa M.F., de Negreiros C.B., Bornstein V.U., Valente R.H., Mengel J., Henriques M., Benjamim C.F., Penido C. (2015) Murine IL-17+ Vgamma4 T lymphocytes accumulate in the lungs and play a protective role during severe sepsis. BMC Immunol 16: 36.
66. Chen D., Luo X., Xie H., Gao Z., Fang H., Huang J. (2013) Characteristics of IL-17 induction by Schistosoma japonicum infection in C57BL/6 mouse liver. Immunology 139: 523–32.
67. Moser E.K., Sun J., Kim T.S., Braciale T.J. (2015) IL-21R signaling suppresses IL-17+ gamma delta T cell responses and production of IL-17 related cytokines in the lung at steady state and after Influenza A virus infection. PLoS ONE 10: e0120169.
68. Babb R., Chen A., Hirst T.R., Kara E.E., McColl S.R., Ogunniyi A.D., Paton J.C., Alsharifi M. (2016) Intranasal vaccination with gamma-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses. Clin Sci (Lond) 130: 697–710.
69. Klemann C., Schroder A., Dreier A., Mohn N., Dippel S., Winterberg T., Wilde A., Yu Y., Thorenz A., Gueler F., Jorns A., Tolosa E., Leonhardt J., Haas J.D., Prinz I., Vieten G., Petersen C., Kuebler J.F. (2016) Interleukin 17, produced by gammadelta t cells, contributes to hepatic inflammation in a mouse model of biliary atresia and is increased in livers of patients. Gastroenterology 150: 229–41e5.
70. Gladiator A., Wangler N., Trautwein-Weidner K., LeibundGut-Landmann S. (2013) Cutting edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190: 521–5.
71. Xu H., Wang X., Liu D.X., Moroney-Rasmussen T., Lackner A.A., Veazey R.S. (2012) IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques. Mucosal Immunol 5: 658–69.
72. Bermejo D.A., Jackson S.W., Gorosito-Serran M., Acosta-Rodriguez E.V., Amezcua-Vesely M.C., Sather B.D., Singh A.K., Khim S., Mucci J., Liggitt D., Campetella O., Oukka M., Gruppi A., Rawlings D.J. (2013) Trypanosoma cruzi trans-sialidase initiates a program independent of the transcription factors RORgammat and Ahr that leads to IL-17 production by activated B cells. Nat Immunol 14: 514–22.
73. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. (2008) The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 6: 288–301.
74. Komatsu N., Okamoto K., Sawa S., Nakashima T., Oh-hora M., Kodama T., Tanaka S., Bluestone J.A., Takayanagi H. (2014) Pathogenic conversion of Foxp3+ T cells into TH17 cells in autoimmune arthritis. Nat Med 20: 62–8.
75. Joller N., Kuchroo V.K. (2014) Good guys gone bad: ExTreg cells promote autoimmune arthritis. Nat Med 20: 15–7.
76. Nadkarni S., Mauri C., Ehrenstein M.R. (2007) Anti-TNF-alpha therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-beta. J Exp Med 204: 33–9.
77. Chen Z., Wang H., D'Souza C., Sun S., Kostenko L., Eckle S.B., Meehan B.S., Jackson D.C., Strugnell R.A., Cao H., Wang N., Fairlie D.P., Liu L., Godfrey D.I., Rossjohn J., McCluskey J., Corbett A.J. (2017) Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals. Mucosal Immunol 10: 58–68.
78. Treiner E., Liblau R.S. (2015) Mucosal-associated invariant T cells in multiple sclerosis: the jury is still out. Front Immunol 6: 503.
79. Li S., Rouphael N., Duraisingham S., Romero-Steiner S., Presnell S., Davis C., Schmidt D.S., Johnson S.E., Milton A., Rajam G., Kasturi S., Carlone G.M., Quinn C., Chaussabel D., Palucka A.K., Mulligan M.J., Ahmed R., Stephens D.S., Nakaya H.I., Pulendran B. (2014) Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol 15: 195–204.
80. Querec T.D., Akondy R.S., Lee E.K., Cao W., Nakaya H.I., Teuwen D., Pirani A., Gernert K., Deng J., Marzolf B., Kennedy K., Wu H., Bennouna S., Oluoch H., Miller J., Vencio R.Z., Mulligan M., Aderem A., Ahmed R., Pulendran B. (2009) Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol 10: 116–25.
81. Obermoser G., Presnell S., Domico K., Xu H., Wang Y., Anguiano E., Thompson-Snipes L., Ranganathan R., Zeitner B., Bjork A., Anderson D., Speake C., Ruchaud E., Skinner J., Alsina L., Sharma M., Dutartre H., Cepika A., Israelsson E., Nguyen P., Nguyen Q.A., Harrod A.C., Zurawski S.M., Pascual V., Ueno H., Nepom G.T., Quinn C., Blankenship D., Palucka K., Banchereau J., Chaussabel D. (2013) Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity 38: 831–44.
82. Bendall S.C., Simonds E.F., Qiu P., Amir el A.D., Krutzik P.O., Finck R., Bruggner R.V., Melamed R., Trejo A., Ornatsky O.I., Balderas R.S., Plevritis S.K., Sachs K., Pe'er D., Tanner S.D., Nolan G.P. (2011) Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science 332: 687–96.
83. Newell E.W., Sigal N., Bendall S.C., Nolan G.P., Davis M.M. (2012) Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity 36: 142–52.
84. Wanke-Jellinek L., Keegan J.W., Dolan J.W., Lederer J.A. (2016) Characterization of lung infection-induced TCRgammadelta T cell phenotypes by CyTOF mass cytometry. J Leukoc Biol 99: 483–93.
85. Goncalves V.M., Dias W.O., Campos I.B., Liberman C., Sbrogio-Almeida M.E., Silva E.P., Cardoso C.P., Jr., Alderson M., Robertson G., Maisonneuve J.F., Tate A., Anderson P., Malley R., Fratelli F., Leite L.C. (2014) Development of a whole cell pneumococcal vaccine: BPL inactivation, cGMP production, and stability. Vaccine 32: 1113–20.
86. Moffitt K.L., Yadav P., Weinberger D.M., Anderson P.W., Malley R. (2012) Broad antibody and T cell reactivity induced by a pneumococcal whole-cell vaccine. Vaccine 30: 4316–22.